Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

APO Medical Opportunities

+ Add to Watchlist

APOMOPP:LX

131.11 EUR 0.13 0.10%

As of 00:59:30 ET on 05/22/2015.

Snapshot for APO Medical Opportunities (APOMOPP)

Year To Date: +13.24% 3-Month: +7.00% 3-Year: +25.92% 52-Week Range: 103.27 - 131.25
1-Month: +0.84% 1-Year: +27.62% 5-Year: +18.86% Beta vs LUXXX: 0.59

Mutual Fund Chart for APOMOPP

No chart data available.
  • APOMOPP:LX 131.11
  • 1M
  • 1Y
Interactive APOMOPP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for APOMOPP

APO Medical Opportunities is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equities of companies from the health care sector.

Inception Date: 08-31-2005 Telephone: 352-260248-1 Tel
Managers: KAI BRUENING / HARALD SCHWARZ
Web Site: www.ipconcept.lu

Fundamentals for APOMOPP

NAV (on 2015-05-22) 131.11
Assets (M) (on 2015-05-22) 190.07
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for APOMOPP

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for APOMOPP

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 0.57
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.96

Top Fund Holdings for APOMOPP

Filing Date: 12/31/2014
Name Position Value % of Total
Novartis AG 66,300 5,123,107 2.999%
Roche Holding AG 21,350 4,792,169 2.805%
Amgen Inc 35,200 4,706,725 2.755%
AbbVie Inc 79,800 4,399,189 2.575%
Abbott Laboratories 110,400 4,133,541 2.420%
Bayer AG 33,950 3,905,948 2.286%
Sanofi 47,850 3,631,815 2.126%
BioMarin Pharmaceutical Inc 46,500 3,520,622 2.061%
H Lundbeck A/S 198,800 3,331,679 1.950%
Edwards Lifesciences Corp 29,100 3,092,308 1.810%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil